Clin Mol Hepatol.  2025 Apr;31(2):e128-e133. 10.3350/cmh.2024.1008.

MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”

Affiliations
  • 1Department of Endocrinology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China
  • 2Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Shandong First Medical University, Jinan, Shandong, China
  • 3Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Haidian District, Beijing, China
  • 4Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Haidian District, Beijing, China
  • 5Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
  • 6Department of Endocrinology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

Keyword

MAFLD; MASLD; Prognosis; Liver disease
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr